Skip to main content
Livermore
Livermore
ZHEN

Bollard Group LLC

SEC CIK
0001556218
Latest filing
Aug 12, 2026

BSX holding history

Boston Scientific Corp in every 13F filed by Bollard Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BSX overviewAll 13F holders of BSXFull Q2 2026 holdings

Shares (Q2 2026)
18,420,720
Value
$786.2M
% of portfolio
23.9%
Quarters held
22
Since Q1 2021
Holdings of BSX by Bollard Group LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202618,420,720$786.2M23.9%−111,453−0.6%ReducedHolders
Q1 202618,532,173$1.16B35.5%−468,296−2.5%ReducedHolders
Q4 202519,000,469$1.81B47.6%−733,104−3.7%ReducedHolders
Q3 202519,733,573$1.93B47.7%−345,870−1.7%ReducedHolders
Q2 202520,079,443$2.16B49.3%−411,383−2.0%ReducedHolders
Q1 202520,490,826$2.07B54.3%−242,400−1.2%ReducedHolders
Q4 202420,733,226$1.85B51.3%−510,325−2.4%ReducedHolders
Q3 202421,243,551$1.78B47.4%−419,750−1.9%ReducedHolders
Q2 202421,663,301$1.67B47.1%−335,320−1.5%ReducedHolders
Q1 202421,998,621$1.51B45.6%−392,890−1.8%ReducedHolders
Q4 202322,391,511$1.29B45.0%−953,215−4.1%ReducedHolders
Q3 202323,344,726$1.23B45.4%−330,355−1.4%ReducedHolders
Q2 202323,675,081$1.28B43.6%−432,545−1.8%ReducedHolders
Q1 202324,107,626$1.21B43.6%−353,200−1.4%ReducedHolders
Q4 202224,460,826$1.13B43.2%−1,278,765−5.0%ReducedHolders
Q3 202225,739,591$996.9M41.9%−456,400−1.7%ReducedHolders
Q2 202226,195,991$976.3M39.6%−437,881−1.6%ReducedHolders
Q1 202226,633,872$1.18B37.7%−329,826−1.2%ReducedHolders
Q4 202126,963,698$1.15B36.7%−193,215−0.7%ReducedHolders
Q3 202127,156,913$1.18B38.6%−2,628,079−8.8%ReducedHolders
Q2 202129,784,992$1.27B40.4%−1,590,099−5.1%ReducedHolders
Q1 202131,375,091$1.21B42.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.